Background: Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is a frequent complication of cotreatment for TB and human immunodeficiency virus (HIV)-1. We characterized (Mtb)-specific CD4 T-cell phenotype and transcription factor profile associated with the development of TB-IRIS.
Methods: We examined the role of CD4 T-cell transcription factors in a murine model of mycobacterial IRIS. In humans, we used a longitudinal study design to compare the magnitude of antiretroviral therapy, activation, transcription factor profile, and cytotoxic potential of Mtb-specific CD4 T cells between TB-IRIS ( = 25) and appropriate non-IRIS control patients ( = 18) using flow cytometry.
Results: In the murine model, CD4 T-cell expression of Eomesodermin (Eomes), but not Tbet, was associated with experimentally induced IRIS. In patients, TB-IRIS onset was associated with the expansion of Mtb-specific IFNγCD4 T cells ( = .039). Patients with TB-IRIS had higher HLA-DR expression ( = .016), but no differences in the expression of T-bet or Eomes were observed. At TB-IRIS onset, EomesTbetMtb-specific IFNγCD4 T cells showed higher expression of granzyme B in patients with TB-IRIS ( = .026).
Conclusions: Although the murine model of complex-IRIS suggests that EomesCD4 T cells underly IRIS, TB-IRIS was not associated with Eomes expression in patients. -specific IFNγCD4 T-cell responses in TB-IRIS patients are differentiated, highly activated, and potentially cytotoxic.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879713 | PMC |
http://dx.doi.org/10.1093/ofid/ofac546 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!